Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
53.85
+10.24 (23.48%)
At close: Apr 28, 2026, 4:00 PM EDT
54.00
+0.15 (0.28%)
After-hours: Apr 28, 2026, 7:59 PM EDT
KNSA Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for KNSA stock have an average target of 58.43, with a low estimate of 50 and a high estimate of 71. The average target predicts an increase of 8.51% from the current stock price of 53.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNSA stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 4 | 4 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $58 → $71 | Strong Buy | Maintains | $58 → $71 | +31.85% | Apr 28, 2026 |
| Wedbush | Wedbush | Buy Maintains $53 → $58 | Buy | Maintains | $53 → $58 | +7.71% | Apr 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | -1.58% | Feb 25, 2026 |
| Wedbush | Wedbush | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | -1.58% | Feb 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +15.13% | Feb 19, 2026 |
Financial Forecast
Revenue This Year
931.53M
from 677.56M
Increased by 37.48%
Revenue Next Year
1.10B
from 931.53M
Increased by 17.87%
EPS This Year
1.05
from 0.75
Increased by 39.63%
EPS Next Year
1.51
from 1.05
Increased by 43.83%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 966.0M | 1.2B | ||||||
| Avg | 931.5M | 1.1B | ||||||
| Low | 888.9M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 42.6% | 27.4% | ||||||
| Avg | 37.5% | 17.9% | ||||||
| Low | 31.2% | 9.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.20 | 1.90 | ||||||
| Avg | 1.05 | 1.51 | ||||||
| Low | 0.80 | 1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 59.6% | 81.5% | ||||||
| Avg | 39.6% | 43.8% | ||||||
| Low | 7.1% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.